Australia markets closed

BioSig Technologies, Inc. (BSGM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2950+0.0150 (+1.17%)
As of 10:57AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-28,738
-29,041
-27,052
-31,917
-52,218
Depreciation & amortisation
266
361
293
198
94
Stock-based compensation
5,590
7,978
4,412
9,500
25,165
Change in working capital
-279
769
464
-3,450
2,351
Accounts receivable
-15
-15
-9
0
-
Inventory
69
-498
284
-1,114
-287
Other working capital
-23,576
-17,499
-21,873
-26,941
-26,688
Other non-cash items
351
293
373
441
4,929
Net cash provided by operating activities
-23,322
-17,313
-21,705
-26,399
-26,601
Cash flows from investing activities
Investments in property, plant and equipment
-254
-186
-168
-542
-87
Net cash used for investing activities
-254
-186
-168
-542
-87
Cash flows from financing activities
Common stock issued
6,928
15,361
10,353
10,304
27,443
Other financing activities
1,971
1,971
-
-
10,592
Net cash used provided by (used for) financing activities
6,928
17,332
10,571
10,332
42,847
Net change in cash
-16,648
-167
-11,302
-16,609
16,159
Cash at beginning of period
17,535
357
11,659
28,268
12,109
Cash at end of period
887
190
357
11,659
28,268
Free cash flow
Operating cash flow
-23,322
-17,313
-21,705
-26,399
-26,601
Capital expenditure
-254
-186
-168
-542
-87
Free cash flow
-23,576
-17,499
-21,873
-26,941
-26,688